Executive Summary

A biopharmaceutical company wanted our help in targeting influential IDNs who would be likely to promote the objectives of their company. We provided a novel method for measuring IDN influence and incentive structure that provided a superior targeted approach compared to other IDN targeting strategies. The details of our method and our client's results are discussed within this case study.

Download

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now